AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02282514 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Hematopoietic Stem Cells
Description: The stem cells will be collected from patient's blood during mobilization. Then the patient will be given high dose chemotherapy in accordance with approved recommendations for use in conditioning regimens for stem cell transplant in autoimmune diseases. Autologous Hematopoietic Stem Cell Transplantation is to re-infuse immature cells that can re-establish blood production and patient's immune system.
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: An alkylating agent which causes prevention of cell division by forming adducts with DNA
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesna
Description: Medication used to decrease the risk of hemorrhagic cystitis prophylaxis
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rATG
Description: A predominantly lymphocyte-specific immunosuppressive agent which contains antibodies specific to the antigens commonly found on the surface of T cells
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Description: Steroid
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Granulocyte-colony stimulating factor; a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cells and release them into the bloodstream
Study NCT02282514 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituxan
Description: A chimeric monoclonal antibody used in the treatment of B cell non-Hodgkin's lymphoma, B cell leukemia, and some autoimmune disorders
Study NCT01103752 — intervention group
Intervention type: OTHER
Intervention: no intervention, descriptive study
Description: no intervention, descriptive study
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Namilumab
Description: Namilumab subcutaneous injection
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Namilumab placebo-matching subcutaneous injection
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Methotrexate tablets
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methotrexate
Description: Methotrexate tablets
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folic/folinic acid
Description: Folic/folinic acid tablets
Study NCT02379091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Folic/folinic acid
Description: Folic/folinic acid tablets
Study NCT02410226 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Double-space combined spinal-epidural anesthesia
Description: Epidural space identification in Lumbar 2-3 or 3-4 space using loss of resistance to air technique with 18-gauge Tuohy needle, then threading a 20-gauge multi-orifice epidural catheter 4-5 cm into the epidural space. Spinal anesthesia administration in an appropriate lower intervertebral space with intrathecal bupivacaine 12.5 mg and fentanyl 10 mcg through a 27-gauge spinal needle.
Study NCT02410226 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Double-space combined spinal-epidural anesthesia
Description: Epidural space identification in Lumbar 2-3 or 3-4 space using loss of resistance to air technique with 18-gauge Tuohy needle, then threading a 20-gauge multi-orifice epidural catheter 4-5 cm into the epidural space. Spinal anesthesia administration in an appropriate lower intervertebral space with intrathecal bupivacaine 12.5 mg and fentanyl 10 mcg through a 27-gauge spinal needle.
Study NCT02410226 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Preprocedure spinal ultrasound
Description: Lumbar spinal ultrasound using the 2-5 MHz curved probe, performed in both the longitudinal and transverse planes for identification of the appropriate intervertebral spce, estimation of the depth to the epidural space, and noting the proper angle for subsequent needle insertion. Then skin markings relying on the ultrasound procedure are made identifying 2 intervertebral spaces.
Study NCT02410226 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Sham ultrasound procedure
Description: Applying the ultrasound probe on the patient's back while the ultrasound machine is on the freeze position.Then skin markings relying on landmark palpation are made identifying 2 intervertebral spaces.
Study NCT04015544 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Watermelon
Description: Pureed whole (100%) watermelon
Study NCT03519633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sugammadex
Description: Reversal of deep NMB
Study NCT03519633 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: Reversal of moderate NMB
Study NCT01698398 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Incremental pump speed of CF-LVAD.
Description: Peak oxygen consumption with fixed versus incremental pump speed.
Study NCT03585751 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulpectomy for primary molars + triple antibiotic mix
Description: complete extirpation of infected pulp from primary molars. Following instrumentation and copious irrigation ,the root canals are filled with one of .Following instrumentation and copious irrigation ,the root canals are filled with a triple antibiotic mix mixed with a Carrier ( MP) as an obturating material
Study NCT03585751 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulpectomy for primary molars + 3mixstatin
Description: complete extirpation of infected pulp from primary molars. Following instrumentation and copious irrigation ,the root canals are filled with one of .Following instrumentation and copious irrigation ,the root canals are filled with 3mixstatin (triple antibiotic mix + simvastatin) as an obturating material mixed with a Carrier ( MP) as an obturating material
Study NCT03585751 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulpectomy for primary molars + simvastatin
Description: complete extirpation of infected pulp from primary molars. Following instrumentation and copious irrigation ,the root canals are filled with simvastatin as mixed with a Carrier ( MP) as an obturating material
Study NCT04202107 — intervention group
Intervention type: OTHER
Intervention: Food Frequency Questionnaire
Description: Food frequency questionnaires (FFQs) are a common method for measuring dietary intake in large epidemiological studies, in particular in low literacy settings were diaries and food history would not be viable.
Study NCT04202107 — intervention group
Intervention type: OTHER
Intervention: 24 Hour food recall
Description: Standardized and validated approach of collecting all foods, beverages, and supplements consumed during the past 24 hours
Study NCT03120897 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAM sensor
Description: Rainbow Acoustic Monitoring sensor for measurement of respiratory rate
Study NCT03710577 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: 1 session
Study NCT03710577 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Quiet Rest
Description: 1 session
Study NCT04258267 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early mobilization
Description: Patients will wear an adduction sling to immobilize the shoulder during the first 4 weeks post-operative
Study NCT04258267 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Delayed mobilization
Description: Patients will wear an abduction sling to immobilize the shoulder during the first 4 weeks post-operative, followed by an adduction sling for 2 weeks.
Study NCT04382352 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Humanized Anti-HER2 Monoclonal Antibody Compound for Injection .R&D code: B002.
Description: Usage: intravenous infusion; B002, doses 2, 6, 12, 16, 20 mg / kg, intravenous drip. The infusion time was 120 ± 10 minutes for the first time; if the patient was tolerated, the follow-up time was adjusted to 60 ± 10 minutes. Pre-treatment was performed using phenergan (25 mg, intramuscular) within 30 minutes prior to each study drug infusion. The dosing cycle is administered once every 3 weeks for one cycle and can be administered continuously until the disease progresses or is intolerable.
Study NCT04773535 — intervention group
Intervention type: DEVICE
Intervention: 3D Motion analysis
Description: Motion analysis using DyCare® Lynx system with inertial based sensors as well as an optoelectronic motion analysis system based on infrared cameras (11x Vicon infrared high speed cameras)
Study NCT02173899 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: varicella-1
Description: Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day
Study NCT02173899 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: varicella-3
Description: Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day
Study NCT02173899 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: varicella-5
Description: Give the second varicella vaccine (a single 0.5 ml) and get blood samples at 0, 35-42 day
Study NCT00332176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celgosivir
Description: 400mg qd + standard of care for 12 weeks
Study NCT00332176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Celgosivir
Description: 600mg qd + standard of care for 12 weeks
Study NCT00332176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Peginterferon alfa 2b + ribavirin
Description: Standard of care for 12 weeks
Study NCT03237455 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic spine x-rays+whole spine MRI
Description: PA radiographs of the thoracic spine and MRI of the whole spine and sacroiliac joints
Study NCT03237455 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Thoracic spine x-rays+whole spine MRI
Description: PA radiographs of the thoracic spine and MRI of the whole spine and sacroiliac joints
Study NCT03237455 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: blood tests
Description: blood chemistry including total cholesterol, LDL HDL, CBC, HbA1C, fasting glucose, TG, and insulin levels, HLA-B27, 2 vials of frozen serum for future studies.
Study NCT03237455 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: blood tests
Description: blood chemistry including total cholesterol, LDL HDL, CBC, HbA1C, fasting glucose, TG, and insulin levels, HLA-B27, 2 vials of frozen serum for future studies.
Study NCT03237455 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: constitutional and demographic data collection
Description: demographics, concomitant diseases (in particular type 2 DM, hypertension, hyperlipidemia) concomitant medications, height and weight (BMI), waist circumference
Study NCT03237455 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: constitutional and demographic data collection
Description: demographics, concomitant diseases (in particular type 2 DM, hypertension, hyperlipidemia) concomitant medications, height and weight (BMI), waist circumference
Study NCT02716480 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobility coaching
Description: The intensive follow-up for the patients of Mobility Coaching  arm will consist on a monthly remote coaching of 20 to 30 minutes led by a Mobility coach. The web platform allows self-administration of a questionnaire to establish patient's diagnosis of mobility to enable personalized coaching. The web platform can also track the parameters collected by connected devices (pedometer and connected scale), organize appointments with patients and ensure the traceability of exchanges with patients. A smartphone application tracks different modes of locomotion used.
Study NCT02716480 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet coaching
Description: The intensive follow-up for the patients of Diet Coaching  arm will consist on a monthly remote coaching of 20 to 30 minutes led by dietitian trained in the care of patients undergoing bariatric surgery.
Study NCT02641288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine irrigation
Description: Using a standard irrigation device (no specific device is being used), 300 mg total of ropivacaine in 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure. Under direct visualization, the solution is delivered over the oesophageal hiatus, over both anastomoses and in both subdiaphragmatic spaces.
Study NCT02641288 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline irrigation
Description: Using a standard irrigation device (no specific device is being used), 200ml normal saline will be instilled into the abdomen after surgical dissection, just before abdominal wall closure.
Study NCT04657393 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical ventilation
Description: change of ventilation frequency
Study NCT00518765 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aliskiren
Study NCT00518765 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aliskiren plus placebo
Study NCT00654771 — intervention group
Intervention type: OTHER
Intervention: urine collection
Description: clean catch urine collection and catheterized urine collection
Study NCT02447003 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: IV infusion of 200 mg.
Study NCT02747836 — intervention group
Intervention type: OTHER
Intervention: Ultrasound of the wrist
Description: using sound waves to create images capturing the movement of the SSCT and flexor tendon and transformation of the median nerve in the wrist
Study NCT01120964 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous L-Citrulline
Study NCT01120964 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo of Intravenous L-Citrulline
Description: Placebo of intravenous L-Citrulline given at the same prescribed times as L-Citrullne Drug
Study NCT01003769 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO
Study NCT01003769 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R-(-)-Gossypol Acetic Acid
Description: Given PO
Study NCT01003769 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT04161157 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pathways
Description: Goal-setting intervention to help patients identify personal values, value-consistent goals, and ways to pursue goals and address goal obstacles. Although potential refinements may occur based on aim 1 (refining procedures and content with 6 patients), Pathways is designed to consist primarily of 2 in-person sessions (\~30-60 minutes) delivered when patients are in clinic for cancer treatment, with supporting phone calls and contact in between sessions.
Study NCT04606602 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SLN360
Description: SLN360 for subcutaneous (s.c.) injection
Study NCT04606602 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sodium chloride for subcutaneous (s.c.) injection
Study NCT01393392 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive, tailored intervention
Description: Eight, 45 minute counseling sessions, tailored to the individual and based on the Information-Motivation-Behavioral Skills model of behavior change. Incorporates motivational interviewing, education, cognitive-behavioral skills training. 12 week course of nicotine replacement patches provided. Nicotine lozenges also provided.
Study NCT01393392 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NJ Quitline Referral
Description: Participants will receive a facilitated referral to the NJ Quitline (i.e. fax to quit).
Study NCT04302077 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: virtual doctor visit
Description: interactive live-video feed at home through EPIC
Study NCT04302077 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care doctor's visit
Description: In person visit as per standard of care
Study NCT06212128 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: RAPIDO TNT
Description: neoadjuvant therapy per RAPIDO protocol (Patients under RAPIDO group underwent 25Gy/5 sessions of short course radiotherapy followed by 6 cycles of neoadjuvant XELOX similar to that of the RAPIDO trial protocol)
Study NCT06212128 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: LCRT
Description: LCRT group underwent conventional 50Gy/25-28 sessions of long course radiotherapy with concurrent oral capecitabine
Study NCT02840461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin Cream, 1%
Study NCT02840461 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ivermectin Cream, 1%
Study NCT02840461 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo/Vehicle cream
Study NCT03810924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test
Description: Test to induce high levels of acute social stress, including actors and a faked exam situation
Study NCT03810924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ergometer
Description: Riding ergometer
Study NCT03810924 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Barlab-Exposure
Description: Participants are exposed to a bar situation with different sorts of alcohol available. They sniff at water and at one alcoholic drink.
Study NCT03810924 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Barlab-Exposure
Description: Participants are exposed to a bar situation with different sorts of alcohol available. They sniff at water and at one alcoholic drink.
Study NCT03810924 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reading Newspaper
Description: Participants read newspaper
Study NCT00735488 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Summary of data
Study NCT02773316 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MR902
Study NCT02773316 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IR morphine sulphate
Study NCT01582269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2157299 monohydrate
Description: Orally administered as tablets
Study NCT01582269 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lomustine
Description: Orally administered as capsules
Study NCT01582269 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lomustine
Description: Orally administered as capsules
Study NCT01582269 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Orally administered as tablets
Study NCT02022124 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microcrystalline cellulose (open-label inert substance)
Description: The intervention will be an inert substance, microcrystalline cellulose in a capsule. Participants will take two capsules daily.
Study NCT03812757 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Supraclavicular fossa US scanning
Description: As previously stated.
Study NCT06603805 — intervention group
Intervention type: PROCEDURE
Intervention: MAST group
Study NCT06603805 — intervention group
Intervention type: PROCEDURE
Intervention: breast-conserving surgery plus adjuvant radiotherapy
Description: Patients with early-stage (stage I, stage II, T≤2), and having the willingness to receive BCS were treated with BCS. All patients with BCS received post-surgery radiotherapy. Radiotherapy was administrated with a prescribed dose of 40 Gy in 15 fractions with photons and a boost of 10-16 Gy in 5-8 fractions with electrons to the ipsilateral breast. If axillary lymph nodes were involved, a conventional fraction was delivered with a prescribed dose of 50 Gy in 25 fractions to the ipsilateral breast and draining lymph node regions.
Study NCT04671017 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLA2001
Description: whole virus inactivated SARS-CoV-2 vaccine adjuvanted with cytosine phospho-guanine (CpG) 1018 in combination with aluminium hydroxide
Study NCT04195841 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Z shaped incision
Description: After local anaesthesia, a mucoperiosteal flap will be elevated at the edentulous ridge with two horizontal incisions placed with a no MB 69 blade, 1-2 mm away from the papilla of the teeth adjacent to the edentulous space following the mesial and distal contour of the teeth. The extend of the incisions should be up to the proximal line angles of the adjacent teeth. These two horizontal incisions are then connected by an oblique incision from the disto-buccal to mesio lingual point angles. A periosteal elevator is used to elevate a full thickness mucoperiosteal flap buccally and lingually to the level of the mucogingival junction, exposing the alveolar ridge of the implant surgical sites.~Endosseous implant placement is done followed by simple interrupted resorbable sutures